Table 1.
Correlations between LAMC1 expression and clinicopathalogic characteristics in 196 patients with HCC
| Clinicopathalogic characteristics | All | High LAMC1 | Low LAMC1 | P value |
|---|---|---|---|---|
| (n=196) | (n=54) | (n=142) | ||
| Age(year) | 48.46±11.64 | 47.74±12.59 | 48.72±11.29 | 0.595 |
| ≤50 | 107 | 32 | 75 | 0.418 |
| >50 | 89 | 22 | 67 | |
| Gender | ||||
| male | 166 | 47 | 119 | 0.574 |
| female | 30 | 7 | 23 | |
| HBsAg | ||||
| negative | 31 | 10 | 21 | 0.523 |
| positive | 165 | 44 | 121 | |
| AFP | ||||
| ≤400ng/ml | 107 | 28 | 79 | 0.635 |
| >400ng/ml | 89 | 26 | 63 | |
| Macro-vascular invasion | ||||
| negative | 160 | 47 | 113 | 0.228 |
| positive | 36 | 7 | 29 | |
| Tumor size(cm) | 7.1±4.0 | 7.3±3.2 | 7±4.3 | 0.23 |
| ≤5cm | 75 | 19 | 56 | 0.584 |
| >5cm | 121 | 35 | 86 | |
| Tumor Number | ||||
| single | 153 | 43 | 110 | 0.744 |
| multiple | 43 | 11 | 32 | |
| Tumor capsule | ||||
| incomplete | 94 | 36 | 58 | 0.014 |
| complete | 102 | 18 | 84 | |
| TNM staging | ||||
| I-II | 141 | 38 | 103 | 0.736 |
| IIIa-IIIb | 55 | 16 | 39 | |
| PLT(109) | 190.9±82.3 | 215.4±111.3 | 181.6±66.3 | 0.058 |
| ALT(U/ml) | 55.0±80.8 | 49.35±41.1 | 57.2±91.5 | 0.888 |
| AST(U/ml) | 48.1±42.6 | 47.1±32.3 | 48.4±50.0 | 0.559 |
| ALB(g/L) | 42.4±4.0 | 42.1±4.1 | 42.5±3.9 | 0.503 |
| TBIL(umol/L) | 19.1±21.7 | 16.7±7.1 | 20.0±25.1 | 0.278 |
| CRE(umol/L) | 77.1±15.2 | 76.2±15.8 | 77.5±15.1 | 0.603 |